Crossmark

The combination therapy of isomucronulatol 7-O-beta-glucoside (IMG) and CEP-9722 targeting ferroptosis-related biomarkers in non-small cell lung cancer (NSCLC)

Crossref DOI link: https://doi.org/10.1186/s12890-023-02445-0

Published Online: 2023-05-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cui, Xiaofei

Liu, Chang

Dong, Penghua

Liu, Chao

Bai, Yu
License Information

Text and Data Mining valid from 2023-05-11

Version of Record valid from 2023-05-11
More Information

Article History

Received: 19 December 2022

Accepted: 18 April 2023

First Online: 11 May 2023

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below